Tandem Diabetes Care, Inc. TNDM
Updated: 17 Jun 2026
No signal published yet
We already track Tandem Diabetes Care and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Tandem Diabetes Care, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Tandem Diabetes Care free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On June 5, 2026, the company announced it received CE Mark clearance in Europe for expanded indications of its automated insulin delivery systems. The approval allows the use of its t:slim X2 and Tandem Mobi systems for adults with type 2 diabetes and pregnant women with type 1 diabetes.
What Firelda Watch includes for Tandem Diabetes Care, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Tandem Diabetes Care, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Tandem Diabetes Care free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more